Email updates

Keep up to date with the latest news and content from Journal of Orthopaedic Surgery and Research and BioMed Central.

Open Access Research article

Long-term follow-up on the use of vascularized fibular graft for the treatment of congenital pseudarthrosis of the tibia

Akio Sakamoto1*, Tatsuya Yoshida1, Yoshio Uchida12, Tetsuo Kojima13, Hideaki Kubota4 and Yukihide Iwamoto1

Author Affiliations

1 Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

2 Uchida Orthopaedic Surgery Hospital, Fukuoka, Japan

3 Mizoguchi Orthopaedic Surgery Hospital, Fukuoka, Japan

4 Saga Handicapped Children's Hospital, Saga, Japan

For all author emails, please log on.

Journal of Orthopaedic Surgery and Research 2008, 3:13  doi:10.1186/1749-799X-3-13

Published: 6 March 2008

Abstract

Background

Congenital pseudoarthrosis of the tibia (CPT) is one of the most difficult conditions to treat.

Methods

Five girls and 3 boys with CPT were treated by vascularized fibular grafting (VFG). The average age at VFG was 7.0 years (range: 1.9–11.5 years) with an average follow-up term of 11.7 years (range: 4.9–19.6 years). Five of the children had undergone multiple operations before VFG, while the other 3 had no such history.

Results

Bone consolidation was obtained in all cases after an average term of 6.6 months (range: 4–10 months); this was with the first VFG in 7 cases but with the second VFG in 1 case. Complication of stress fracture and ankle pain occurred in 1 and 3 cases, respectively, only in cases undergoing multiple operations. Leg-length discrepancy was more prominent in the patients with multiple previous operations (mean: 7.5 cm), than in the cases with no prior surgery (mean: 0.7 cm).

Conclusion

The long-term results of VFG for CPT were excellent, especially in the cases, with no prior surgery. VFG should be considered as a primary treatment option for CPT.